Flavone attenuates vascular contractions by inhibiting RhoA/Rho kinase pathway

Korean Journal of Physiology and Pharmacology

Volumn 13, Issue 3, 2009, Pages 201-207

  Baek, Inji ^a   Su, Bun Jeon ^a   Song, Min Ji ^a   Yang, Enyue ^a   Uy, Dong Sohn ^b   Kim, In Kyeom ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

CPI 17; Flavone; MYPT1; Rho kinase; RhoA; Vasorelaxation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; FLAVONE; FLUORESCEIN SODIUM; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN PHOSPHATASE; MYOSIN LIGHT CHAIN PHOSPHATASE 17KDA; MYOSIN PHOSPHATASE TARGETING SUBUNIT 1; PROTEIN KINASE C; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 67651034021     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2009.13.3.201     Document Type: Article

References (39)

1. Ajay M, Achike FI, Mustafa MR. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid. Pharmacol Res 55: 385-391, 2007. (Pubitemid 46560390)
2. Ajay M, Gilani AU, Mustafa MR. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci 74: 603-612, 2003. (Pubitemid 37410351)
3. 2+ regulation of phosphoinositide 3-kinase C2alpha, Rho, and myosin phosphatase in vascular smooth muscle. J Pharmacol Exp Ther 320: 907-916, 2007.
4. Cassidy A, Hanley B, Lamuela-Raventos RM. Isoflavones, lignans and stilbenes - origins, metabolism and potential importance to human health. J Sci Food Agricult 80: 1044-1062, 2000. (Pubitemid 30319398)
5. Chan EC, Pannangpetch P, Woodman OL. Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure-activity relationships. J Cardiovasc Pharmacol 35: 326-333, 2000. (Pubitemid 30073828)
6. Duarte J, Perez Vizcaino F, Utrilla P, Jiménez J, Tamargo J, Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen Pharmacol 24: 857-862, 1993. (Pubitemid 23240133)
7. Duffy C, Perez K, Partridge A. Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin 57: 260-277, 2007. (Pubitemid 47620124)
8. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem (Tokyo) 118: 1104-1107, 1995. (Pubitemid 26013794)
9. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265: H774-778, 2000.
10. Fitzpatrick LA. Alternatives to estrogen. Med Clin North Am 87: 1091-1113, 2003.
11. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22: 32-39, 2001. (Pubitemid 32126284)
12. Ghisdal P, Vandenberg G, Morel N. Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries. J Physiol 551: 855-867, 2003. (Pubitemid 37221078)
13. Gohla A, Schultz G, Offermanns S. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ Res 87: 221-227, 2000.
14. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, Bollag G. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 280: 2112-2114, 1998. (Pubitemid 28366203)
15. Herrera MD, Zarzuelo A, Jimenez J, Marhuenda E, Duarte J. Effects of flavonoids on rat aortic smooth muscle contractility: Structure-activity relationships. Gen Pharmacol 27: 273-277, 1996. (Pubitemid 26129187)
16. Hirata K, Kikuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y, Seki H, Saida K, Takai Y. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 267: 8719-8722, 1992.
17. Jeon SB, Jin F, Kim JI, Kim SH, Suk K, Chae SC, Jun JE, Park WH, Kim IK. A role for Rho kinase in vascular contraction evoked by sodium fluoride. Biochem Biophys Res Commun 343: 27-33, 2006.
18. Jeon SB, Kim G, Kim JI, Seek YM, Kim SH, Suk K, Shin HM, Lee YH, Kim IK. Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphatase target subunit. Clin Exp Pharmacol Physiol 34: 1116-1120, 2007. (Pubitemid 47416344)
19. Johns DG, Dorrance AM, Leite R, Weber DS, Webb RC. Novel signaling pathways contributing to vascular changes in hypertension. J Biomed Sci 7: 431-443, 2000. (Pubitemid 30825328)
20. Kim IK, Park TG, Kim YH, Cho JW, Kang BS, Kim CY. Heat-shock response is associated with enhanced contractility of vascular smooth muscle in isolated rat aorta. Naunyn Schmiedebergs Arch Pharmacol 369: 402-407, 2004.
21. Kim JI, Jeon SB, Baek I, Seok YM, Shin HM, Kim EK. Heat shock augments myosin phosphatase target-subunit phosphorylation. Biochem Biophys Res Commun 356: 718-722, 2007. (Pubitemid 46499024)
22. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248, 1996. (Pubitemid 26285892)
23. Ko F, Huang T, Teng C. Vasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta. Biochim Biophys Acta 1115: 69-74, 1991.
24. Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, Nakano T. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475: 197-200, 2000. (Pubitemid 30408452)
25. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, Ito M. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 272: 12257-12260, 1997. (Pubitemid 27203307)
26. Lee HA, Seong Y, Lee WJ, Kim I. 17 β-Estradiol inhibits calcium-dependent, but not calcium-independent, contraction in isolated rat aorta. Naunyn Schmiedebergs Arch Pharmacol 371: 152-157, 2005. (Pubitemid 40487420)
27. Machha A, Mustafa MR. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol 46: 36-40, 2005. (Pubitemid 40917776)
28. Most MM. Estimated phytochemical content of the dietary approaches to stop hypertension (DASH) diet is higher than in the Control Study Diet. J Am Diet Assoc 104: 1725-1727, 2004.
29. National Institutes of Health. Guide for the care and use of laboratory animals. NIH publication No. 85-123, revised edn. NIH, Bethesda, MD, 1996.
30. Pang H, Guo Z, Su W, Xie Z, Eto M, Gong MC. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am J Physiol Cell Physiol 289: 352-360, 2005. (Pubitemid 41014837)
31. Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review J Nutr Biochem 16: 321-330, 2005. (Pubitemid 40776040)
32. Sakurada S, Takuwa N, Sugimoto N, Takuwa Y. Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol Cell Physiol 281: C571-578, 2001. (Pubitemid 32751260)
33. 2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
34. Tsai MH, Jiang MJ. Rho-kinase-mediated regulation of receptor-agonist- stimulated smooth muscle contraction. Pflugers Arch 435: 223-232, 2006. (Pubitemid 44630456)
35. Wang Y, Yoshioka K, Azam MA, Takuwa N, Sakurada S, Kayaba Y, Sugimoto N, Inoki I, Kimura T, Kuwaki T, Takuwa Y. Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochem J 394: 581-592, 2006.
36. 2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem J 389: 763-774, 2005. (Pubitemid 41121989)
37. Wirth A, Benyó Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S, Orsy P, Horváth B, Maser-Gluth C, Greiner E, Lemmer B, Schütz G, Gutkind JS, Offermanns S. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 14: 64-68, 2008.
38. Zenebe W, Pechanova O, Bernatova I. Protective effects of red wine polyphenolic compounds on the cardiovascular system. Exp Clin Cardiol 6: 153-158, 2001. (Pubitemid 34232354)
39. Zern TL, Fernandez ML. Cardioprotective effects of dietary polyphenols. J Nutr 135: 2291-2294, 2005.